Health Affairs, 24, no. 1 (2005): 195-205 doi: 10.1377/hlthaff.24.1.195 © 2005 by Project HOPE	New Online   How Would Obama, McCain Cover The Uninsured?   Debating Cost Of Uninsured   Try Medicare-For-All   HA Blog Top 10

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (31) Citing Articles via Google Scholar Google Scholar Articles by Zuvekas, S. H. Search for Related Content PubMed PubMed Citation Articles by Zuvekas, S. H. Related Collections Insurance Market Access To Care Business Of Health Consumer Issues Health Reform Insurance Coverage Insurance - Employer-Based System Mental Health/Substance Abuse Pharmaceuticals Health Spending

Health Tracking

TRENDS

Prescription Drugs And The Changing Patterns Of Treatment For Mental Disorders, 1996–2001

This paper uses detailed data on prescription drug and other services from the Medical Expenditure Panel Survey (MEPS) to examine recent trends in mental health and substance abuse (MH/SA) treatment between 1996 and 2001. While use of ambulatory services remained constant, prescription drug use increased rapidly, with the result that 5.5 million more Americans received treatment in 2001. Prescription drug spending increased at a real rate of almost 20 percent a year. About one-third of this increase came from more MH/SA medication users and two-thirds from higher costs per user.

                      What's this?

This article has been cited by other articles:

				J. M. Donohue and R. G. Frank Estimating Medicare Part D's Impact on Medication Access Among Dually Eligible Beneficiaries With Mental Disorders Psychiatr Serv, October 1, 2007; 58(10): 1285 - 1291. [Abstract] [Full Text] [PDF]

				T. L. Mark, K. R. Levit, J. A. Buck, R. M. Coffey, and R. Vandivort-Warren Mental Health Treatment Expenditure Trends, 1986 2003 Psychiatr Serv, August 1, 2007; 58(8): 1041 - 1048. [Abstract] [Full Text] [PDF]

				J. M. Polinski, P. S. Wang, and M. A. Fischer Medicaid's Prior Authorization Program And Access To Atypical Antipsychotic Medications Health Aff., May 1, 2007; 26(3): 750 - 760. [Abstract] [Full Text] [PDF]

				B. G. Druss Rising mental health costs: what are we getting for our money? Health Aff., May 1, 2006; 25(3): 614 - 622. [Abstract] [Full Text] [PDF]

				H. A. Huskamp Prices, profits, and innovation: examining criticisms of new psychotropic drugs' value. Health Aff., May 1, 2006; 25(3): 635 - 646. [Abstract] [Full Text] [PDF]

				J. Donohue Mental health in the medicare part d drug benefit: a new regulatory model? Health Aff., May 1, 2006; 25(3): 707 - 719. [Abstract] [Full Text] [PDF]

				N. E. Morden and L. P. Garrison Jr. Implications of part d for mentally ill dual eligibles: a challenge for medicare. Health Aff., March 1, 2006; 25(2): 491 - 500. [Abstract] [Full Text] [PDF]

				S. H. Zuvekas, A. E. Rupp, and G. S. Norquist The Impacts Of Mental Health Parity And Managed Care In One Large Employer Group: A Reexamination Health Aff., November 1, 2005; 24(6): 1668 - 1671. [Abstract] [Full Text] [PDF]

				P. Rosenfeld, H. Kim, G. Londono, C. Kovner, and M. Mezey Adult Ambulatory Care Visits to Nurses and Physicians: Methodological Limitations of the Medical Expenditure Panel Survey Data Policy Politics Nursing Practice, August 1, 2005; 6(3): 221 - 228. [Abstract] [PDF]